Nexscient Inc (NXNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 755 | 29 | 59 | 101 | 21 |
| TOTAL | $808 | $115 | $99 | $160 | $35 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 168 | 172 | 137 | 141 | 146 |
| TOTAL | $168 | $172 | $137 | $141 | $146 |
| Total Assets | $976 | $288 | $235 | $302 | $181 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 330 | 265 | N/A | 0 | 30 |
| Accounts payable and accrued liabilities | 33 | 25 | 8 | 15 | 13 |
| Accrued Expenses | 43 | 30 | N/A | N/A | N/A |
| TOTAL | $622 | $486 | $104 | $65 | $53 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 197 | 146 | 95 | 44 | N/A |
| Other Non-Current Liabilities | 227 | 298 | 563 | 501 | 344 |
| TOTAL | $227 | $298 | $563 | $501 | $344 |
| Total Liabilities | $849 | $784 | $667 | $566 | $397 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,695 | 21,663 | 21,623 | 21,323 | 21,173 |
| Common Shares | 25 | 22 | 21 | 21 | 21 |
| Retained earnings | -2,005 | -1,878 | -1,728 | -1,561 | -1,454 |
| TOTAL | $127 | $-496 | $-432 | $-265 | $-216 |
| Total Liabilities And Equity | $976 | $288 | $235 | $302 | $181 |